We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-1.68%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.43B
AUM Growth
+$172M
Cap. Flow
+$215M
Cap. Flow %
15.04%
Top 10 Hldgs %
3.57%
Holding
2,136
New
582
Increased
568
Reduced
423
Closed
559

Top Sells

Rank Stock Value
1
JBSS icon
John B. Sanfilippo & Son
JBSS
+$3.41M
2
APA icon
APA Corp
APA
+$3.31M
3
ZTS icon
Zoetis
ZTS
+$3.2M
4
UGI icon
UGI
UGI
+$3.03M
5
DOCU
DocuSign
DOCU
+$2.87M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Healthcare 13.4%
3 Consumer Discretionary 13.25%
4 Financials 12.49%
5 Industrials 11.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SSP icon
1501
E.W. Scripps
SSP
$304M
$134K 0.01%
+42,646
New +$135K
HLMN icon
1502
Hillman Solutions
HLMN
$1.79B
$133K 0.01%
+15,024
New +$142K
RITM icon
1503
Rithm Capital
RITM
$5.69B
$133K 0.01%
12,211
-23,509
-66% -$260K
CAPR icon
1504
Capricor Therapeutics
CAPR
$237M
$130K 0.01%
+27,330
New +$152K
IMUX icon
1505
Immunic
IMUX
$195M
$130K 0.01%
+11,677
New +$145K
SGU icon
1506
Star Group
SGU
$423M
$129K 0.01%
12,085
-4,672
-28% -$50.3K
GPMT
1507
Granite Point Mortgage Trust
GPMT
$61.2M
$128K 0.01%
43,122
-50,418
-54% -$187K
GOTU icon
1508
Gaotu Techedu
GOTU
$436M
$127K 0.01%
+25,985
New +$163K
OPRT icon
1509
Oportun Financial
OPRT
$372M
$126K 0.01%
43,497
-8,368
-16% -$25.4K
PMVP icon
1510
PMV Pharmaceuticals
PMVP
$63.5M
$126K 0.01%
77,743
+38,106
+96% +$68.7K
CINT icon
1511
CI&T Inc
CINT
$458M
$125K 0.01%
+24,015
New +$103K
EYPT icon
1512
EyePoint Inc
EYPT
$1.2B
$125K 0.01%
+14,363
New +$201K
MAGN
1513
Magnera Corp
MAGN
$460M
$125K 0.01%
6,921
-1,335
-16% -$28.7K
PGEN icon
1514
Precigen
PGEN
$2.59B
$121K 0.01%
76,429
-146,859
-66% -$213K
ADT icon
1515
ADT
ADT
$5.58B
$119K 0.01%
15,689
-135,712
-90% -$940K
PERI icon
1516
Perion Network
PERI
$386M
$119K 0.01%
14,259
-22,222
-61% -$270K
RC
1517
Ready Capital
RC
$308M
$118K 0.01%
+14,422
New +$123K
AIRS icon
1518
AirSculpt Technologies
AIRS
$353M
$116K 0.01%
29,082
-84,012
-74% -$403K
MRSN
1519
DELISTED
Mersana Therapeutics
MRSN
$116K 0.01%
2,318
+908
+64% +$65.7K
RAPT
1520
DELISTED
RAPT Therapeutics
RAPT
$112K 0.01%
+4,582
New +$212K
SABR icon
1521
Sabre
SABR
$818M
$110K 0.01%
+41,158
New +$115K
IQ icon
1522
iQIYI
IQ
$1.28B
$108K 0.01%
+29,393
New +$133K
NNBR icon
1523
NN Inc
NNBR
$291M
$108K 0.01%
+35,909
New +$126K
NRGV icon
1524
Energy Vault
NRGV
$633M
$108K 0.01%
+113,264
New +$141K
CCCC icon
1525
C4 Therapeutics
CCCC
$412M
$107K 0.01%
23,268
-25,495
-52% -$152K

Similar funds

GSA Capital Partners's Q2 2024 Portfolio in Review

As of Q2 2024, GSA Capital Partners held 2,136 positions worth $1.43B, up 14% from $1.26B the previous quarter. Its ten largest holdings account for 3.6% of the portfolio.

GSA Capital Partners deployed $215M of net new capital in Q2 2024, opening 582 new positions and adding to 568 existing holdings. Its largest new stake was Genuine Parts: 28,253 shares worth $3.91M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was UGI, an estimated $3.03M trimmed.

  • GSA Capital Partners's largest Q2 2024 buy was Genuine Parts: 28,253 shares worth $3.91M.
  • GSA Capital Partners added most to Devon Energy in Q2 2024, an estimated $5.97M increase.
  • GSA Capital Partners's biggest Q2 2024 reduction was UGI, cutting an estimated $3.03M.
  • GSA Capital Partners fully exited John B. Sanfilippo & Son in Q2 2024, selling an estimated $3.41M.
  • GSA Capital Partners's ten largest holdings make up 3.6% of its $1.43B portfolio in Q2 2024.
  • GSA Capital Partners opened 582 new positions and closed 559 in Q2 2024.
  • GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $1.43B.

Based on GSA Capital Partners's 13F filing for Q2 2024, filed 15 Aug 2024.